ABPI Disclaimer


CVRM Professional Care is sponsored by the pharmaceutical and med tech industries via Grants, Sponsorship, and Exhibition packages. Pharmaceutical companies have solely provided sponsorship through the purchase of exhibition space and/or sponsored speaker sessions with no further input into the arrangements or agenda of the meeting. Sessions delivered with input from our sponsors will always be marked on the programme. A full list of confirmed sponsors for CVRM Professional Care is available here.
 

Conference Programme

CVRM Professional Care features a dedicated programme across three theatres designed to support healthcare professionals working across cardiovascular, renal and metabolic care in primary and secondary care settings. Sessions will cater to a wide range of roles, including consultants, GPs, specialist nurses, ICS & ICB members, clinical leads, pharmacists, and others involved in prevention, diagnosis, treatment, and long-term patient management. The programme will also include focused content on key specialist areas across CVRM, helping attendees stay up to date with the latest guidance, clinical insights and practical approaches to improving patient outcomes. See the full list of theatres below.

CVRM Professional Care is sponsored by the pharmaceutical and med tech industries via grants, sponsorship, and exhibition packages. Pharmaceutical companies have solely provided sponsorship through the purchase of exhibition space and/or sponsored speaker sessions with no further input into the arrangements or agenda of the meeting. Sessions delivered with input from our sponsors will always be marked on the programme.

Sessions will still keep getting added as they get confirmed so keep checking back for updates.

Keynote Theatre
  1. Keynote Theatre
  2. Keynote Theatre
  3. Keynote Theatre
  4. Keynote Theatre
  5. Keynote Theatre
    .
  6. Keynote Theatre
Clinical Theatre
  1. Clinical Theatre
  2. Clinical Theatre
  3. Clinical Theatre
    Overcoming barriers to cardiorenal optimisation: A practical guide for managing chronic hyperkalaemia
    This is a promotional symposium sponsored and organised by AstraZeneca and is intended for UK HCPs only.
  4. Clinical Theatre
  5. Clinical Theatre
  6. Clinical Theatre
  7. Clinical Theatre
  8. Clinical Theatre
Integrated Care & Pathways Theatre
  1. Integrated Care & Pathways Theatre
    The unexpected impact of infections on long-term conditions
  2. Integrated Care & Pathways Theatre
  3. Integrated Care & Pathways Theatre
  4. Integrated Care & Pathways Theatre
    Discussion of patient centred care Involvement of technology Collaboration and shared decision making are central to the discussion. Showcasing the role of specialist nurses
  5. Integrated Care & Pathways Theatre
  6. Integrated Care & Pathways Theatre
  7. Integrated Care & Pathways Theatre
  8. Integrated Care & Pathways Theatre
Keynote Theatre
  1. Keynote Theatre
  2. Keynote Theatre
    This session will provide an authoritative overview of the current NICE recommendations and their pr ...
  3. Keynote Theatre
  4. Keynote Theatre
    Modern Service Framework: cardiovascular disease - what does this mean for me?
  5. Keynote Theatre
    In this session we will highlight the key principles needed to translating CVRM concepts into routine practice.
  6. Keynote Theatre
    Ultra-processed food addiction is an emerging area of clinical and research interest. For some patients, repeated difficulty changing dietary patterns may not be due to lack of knowledge, motivation or willpower, but to cravings, loss of control and relapse patterns that resemble addiction. This session will provide a brief overview of UPFA and present findings from the Liberate intervention, an online, peer-supported, addiction-informed psychoeducation programme for adults self-identifying with ultra-processed food addiction. It will explore how UPFA may overlap with binge eating symptoms and why this matters for clinicians supporting patients with obesity, type 2 diabetes, metabolic disease or repeated dietary relapse. The presentation will then translate these findings into practical clinical considerations, including how to recognise possible UPFA, how to ask non-shaming questions, how to use CRAVED as a brief screening tool.
  7. Keynote Theatre
Clinical Theatre
  1. Clinical Theatre
    Closing the lipid gap: evidence-based management before specialist referral
  2. Clinical Theatre
    PMOS is the most common endocrine disorder affecting women worldwide. Its symptoms, including excess facial hair, adult acne, alopecia, challenges with weight management and chronic fatigue can affect self-esteem, ability to manage the condition and confidence. PMOS carries an increased risk of type 2 diabetes, cardiovascular disease, fatty liver disease, endometrial cancer, sleep apnoea, miscarriage, gestational diabetes, depression, anxiety, eating disorders, and suicidality. A comprehensive medical renaming process after 14 years of global collaboration has happened.
  3. Clinical Theatre
    Overcoming barriers to cardiorenal optimisation: A practical guide for managing chronic hyperkalaemia
    This is a promotional symposium sponsored and organised by AstraZeneca and is intended for UK HCPs only.
  4. Clinical Theatre
  5. Clinical Theatre
    Balancing polypharmacy and deprescribing in CVRM
  6. Clinical Theatre
    Accurate diagnosis, coding and evidence based management of Hf in primary care.
  7. Clinical Theatre
  8. Clinical Theatre
Integrated Care & Pathways Theatre
  1. Integrated Care & Pathways Theatre
  2. Integrated Care & Pathways Theatre
  3. Integrated Care & Pathways Theatre
  4. Integrated Care & Pathways Theatre
  5. Integrated Care & Pathways Theatre
  6. Integrated Care & Pathways Theatre
  7. Integrated Care & Pathways Theatre
    Making diabetes checks easier to complete


 

Partners